Catalyst Wire Dossier Catalyst Wire Dossier

MEDI8897

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MEDI8897, covering 2016-11-28 to 2024-02-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY) [Phase 3]

See pricing